In this article, we will take a look at the 5 largest ophthalmology companies in the world. If you want to see more companies in this selection, go to the 15 Largest Ophthalmology Companies in the World.
5. Novartis AG (SWX:NOVN)
Novartis AG (SWX:NOVN) is a Basel, Switzerland-based global healthcare company with a well-established ophthalmology division. The company’s drug portfolio includes medications for a wide variety of conditions, such as age-related macular degeneration, glaucoma, and retinal vein occlusion. Some of their notable products in Novartis AG’s (SWX:NOVN) ophthalmology division include Lucentis and Beovu for age-related macular degeneration and Tafinlar and Mekinist for melanoma. The company also has a pipeline of investigational drugs for various ophthalmic conditions, such as diabetic macular edema and retinitis pigmentosa.
4. Johnson & Johnson Vision
2021 Revenue: $4.8 billion
Johnson & Johnson Vision is an Irvine, California-based company that is a division of New Brunswick, New Jersey-based Johnson & Johnson Inc (NYSE:JNJ).
Johnson & Johnson Vision specializes in ophthalmology products and services as it develops, manufactures, and markets a wide range of products and technologies for eye care professionals, including contact lenses, surgical equipment, and pharmaceuticals. Some of the most well-known products offered by Johnson & Johnson Vision include the ACUVUE brand of contact lenses, the Vistakon division, which is the world’s leading provider of disposable contact lenses, and the AMO division, which specializes in cataract and refractive surgery devices and technologies. Johnson & Johnson Vision also offers a range of diagnostic equipment, such as the CompacT Seeker, used to measure the eye for contact lenses and other devices.
Here’s what Distillate Capital Partners LLC said about Johnson & Johnson Inc (NYSE:JNJ) in its Q2 2022 investor letter:
“Johnson & Johnson was among the 2 largest trims at around 1% each. Each stock was up 1% in the quarter compared to the 16% price decline for the S&P 500 and the positions were reduced as the valuations became somewhat less appealing, though still attractive enough to warrant inclusion.”
3. HOYA Corporation (OTC:HOCPF)
2021 Revenue: $5.04 billion
HOYA Corporation (OTC:HOCPF) is a Tokyo, Japan-based medical technology company founded in 1941 that specializes in the development, manufacturing, and distribution of ophthalmic products and equipment for eye care professionals. Hoya Corporation has a headcount of 38,376 employees with 160 offices and subsidiaries globally.
Hoya Corporation’s product portfolio includes a range of IOLs for cataract surgery, such as the Hoyalux iD MyStyle, designed to correct presbyopia, and the Hoyalux iD LifeStyle, which is designed to treat astigmatism. The company also has a wide range of diagnostic equipment, such as the Hoya ConBio Medlite C6 laser, used for a variety of ophthalmic procedures, and the Hoya ConBio RevLite laser, which is used for laser skin resurfacing.
2. Alcon Inc. (NYSE:ALC)
2021 Revenue: $8.3 billion
Alcon Inc. (NYSE:ALC) is a Geneva, Switzerland-based global medical company specializing in eye care products and devices.
Alcon Inc. (NYSE:ALC) offers a wide range of products and services for eye care professionals, including cataract and refractive surgery devices, intraocular lenses, ocular pharmaceuticals, and contact lenses. Some of Alcon’s most well-known products include the AcrySof intraocular lens, which is used in cataract surgery, and the Dailies contact lenses. Alcon Inc. (NYSE:ALC) also offers a range of surgical equipment and instruments, such as the LenSx laser and the Centurion Vision System, which are used to perform advanced cataract and refractive surgeries.
Follow Alcon Inc (NYSE:ALC)
Follow Alcon Inc (NYSE:ALC)
1. EssilorLuxottica SA (EPA:EL)
2021 Revenue: $23.5 billion
Essilor International is a Charenton-le-Pont, France-based ophthalmic-focused company founded in 1849. The company specializes in the development, manufacturing, and distribution of ophthalmic lenses, equipment, and instruments for eye care professionals. The entity offers a wide range of products for various ophthalmic conditions such as myopia, hyperopia, astigmatism, and presbyopia.
The product portfolio of EssilorLuxottica SA (EPA:EL) includes progressive lenses, single-vision lenses, polarized lenses, photochromic lenses, and other lens coatings. The company also develops and markets various lens edging systems, measurement devices, and other equipment for eye care professionals. EssilorLuxottica SA (EPA:EL) has recently developed the Eyezen lens, designed to reduce the symptoms of digital eye strain, and the Varilux X series, which is a progressive lens designed to provide wider fields of vision.
Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also take a peek at the 12 Best Biofuel Stocks To Buy and the 13 Largest Gold Mines in the World.
